Checchi Capital Advisers, LLC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 312 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2021. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
Checchi Capital Advisers, LLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$249,423
+9.6%
16,123
+11.3%
0.02%
+15.0%
Q2 2023$227,638
+0.6%
14,490
+5.5%
0.02%
-9.1%
Q1 2023$226,303
+5.3%
13,732
-0.3%
0.02%0.0%
Q4 2022$214,859
+19.4%
13,773
-1.0%
0.02%
+29.4%
Q3 2022$180,000
-8.2%
13,909
+3.7%
0.02%0.0%
Q2 2022$196,000
+5.4%
13,414
+3.4%
0.02%
+6.2%
Q1 2022$186,000
+19.2%
12,967
+13.3%
0.02%
+14.3%
Q4 2021$156,000
-44.1%
11,449
-32.9%
0.01%
-50.0%
Q3 2021$279,000
-2.8%
17,063
+0.2%
0.03%0.0%
Q2 2021$287,000
-9.2%
17,037
-1.6%
0.03%
-9.7%
Q1 2021$316,000
+0.3%
17,322
+0.1%
0.03%
-3.1%
Q4 2020$315,000
-12.0%
17,309
-13.6%
0.03%
-20.0%
Q3 2020$358,000
-3.0%
20,042
-2.6%
0.04%
-9.1%
Q2 2020$369,000
+23.8%
20,579
+4.8%
0.04%
+51.7%
Q1 2020$298,000
-18.1%
19,642
+6.4%
0.03%
-40.8%
Q4 2019$364,000
+46.2%
18,467
+27.6%
0.05%
+53.1%
Q3 2019$249,000
+0.8%
14,477
+3.9%
0.03%
+3.2%
Q2 2019$247,000
-25.4%
13,930
-14.2%
0.03%
-20.5%
Q1 2019$331,00016,2320.04%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q1 2021
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 30,201$3,149,00019.29%
MANAGED ASSET PORTFOLIOS, LLC 1,399,878$20,046,0002.75%
Clean Yield Group 251,220$3,597,0001.27%
Mondrian Investment Partners LTD 4,319,715$60,476,0001.24%
Sippican Capital Advisors 80,490$1,153,0000.96%
TFG Asset Management GP Ltd 1,275,656$18,268,0000.83%
Lumbard & Kellner, LLC 132,516$1,898,0000.74%
BRANDES INVESTMENT PARTNERS, LP 2,109,846$30,213,0000.65%
CAUSEWAY CAPITAL MANAGEMENT LLC 1,601,046$22,927,0000.55%
Ridgewood Investments LLC 33,378$478,0000.31%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders